Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH)

被引：0
|
作者：
Gamba, G. [1 ]
Montani, N. [1 ]
Trinchero, A. [1 ]
Pecci, A. [1 ]
Bertolino, G. P. [1 ]
Lodo, F. [1 ]
机构：
[1] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Internal Med, Haemophilia Ctr, I-27100 Pavia, Italy
来源：
HAEMOPHILIA | 2010年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [1] CHARACTERIZATION OF FACTOR-VIII-INHIBITOR BY-PASSING ACTIVITY (FEIBA)
    HESS, K
    SHIH, N
    TISHKOFF, G
    THROMBOSIS AND HAEMOSTASIS, 1977, 38 (01) : 188 - 188
  • [2] FACTOR-VIII INHIBITOR BY-PASSING ACTIVITY (FEIBA) IN MANAGEMENT OF PATIENTS WITH FACTOR-VIII INHIBITORS
    PRESTON, FE
    DINSDALE, RCW
    SUTCLIFFE, DJ
    BARDHAN, G
    WYLD, PJ
    HAMLYN, JF
    THROMBOSIS RESEARCH, 1977, 11 (05) : 643 - 651
  • [3] THE USE OF FACTOR-VIII INHIBITOR BY-PASSING ACTIVITY (FEIBA IMMUNO) PRODUCT FOR TREATMENT OF BLEEDING EPISODES IN HEMOPHILIACS WITH INHIBITORS
    HILGARTNER, MW
    KNATTERUD, GL
    BLOOD, 1983, 61 (01) : 36 - 40
  • [4] Efficacy and Safety of FEIBA Prophylaxis Evaluation in Young Patients With Haemophilia and High Titer Inhibitor
    Karimi, M.
    Tavoosi, H.
    Haghpanah, S.
    Ardeshiri, R.
    Zarei, T.
    HAEMOPHILIA, 2015, 21 : 42 - 42
  • [5] Safety of factor VIII inhibitor bypass activity (FEIBA®):: 10-year compilation of thrombotic adverse events
    Ehrlich, HJ
    Henzl, MJ
    Gomperts, ED
    HAEMOPHILIA, 2002, 8 (02) : 83 - 90
  • [6] Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues
    Aledort, L. M.
    HAEMOPHILIA, 2008, 14 (01) : 39 - 43
  • [7] Efficacy and safety of factor VIII inhibitor bypass activity (Feiba) for long-term prophylaxis in patients with high-responding inhibitors.
    Kreuz, W
    Escuriola-Ettinghausen, C
    Martinez, I
    Mentzer, D
    Figura, S
    Klarmann, D
    BLOOD, 2000, 96 (11) : 265A - 265A
  • [8] Thrombotic events are very rare after infusion of factor VIII inhibitor bypass activity (Feiba).
    Ehrlich, HJ
    Henzl, MJ
    Gomperts, ED
    BLOOD, 2000, 96 (11) : 82B - 82B
  • [9] Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma
    Livnat, T.
    Martinowitz, U.
    Zivelin, A.
    Seligsohn, U.
    HAEMOPHILIA, 2008, 14 (04) : 782 - 786
  • [10] Ten years' experience with Factor Eight Bypassing Activity (FEIBA) in patients with acquired VIII inhibitors.
    Sallah, AS
    BLOOD, 2002, 100 (11) : 700A - 700A
12345